Tendinitis That Won't Go Away: PRP vs. Cortisone Injections

You trained through the discomfort. You rested, iced, and took ibuprofen. You backed off for two weeks, maybe four. And yet the pain is still there — nagging, limiting, and standing between you and the sport or activity you love. If this sounds familiar, you are not alone. Persistent tendon pain is one of the most frustrating injuries in sports medicine, and it sends thousands of athletes and active professionals searching for answers every year. Many of them are now exploring tendinitis treatment Princeton NJ with injection-based therapies, particularly the growing interest in platelet-rich plasma (PRP) compared to the more established cortisone injection. Understanding what each option actually does — and what the evidence genuinely supports — is essential before committing to either.

Tendinitis vs. Tendinopathy: Why Your Tendon Pain Won't Go Away

The term "tendinitis" implies inflammation. Technically, it describes an acute condition where a tendon becomes irritated and inflamed, typically from a sudden increase in load or activity. Rest, anti-inflammatories, and modified activity often resolve it within weeks.

Tendinopathy is a different story. This term describes a degenerative process in which the tendon's internal structure has broken down — collagen fibers become disorganized, blood vessel growth is abnormal, and the tissue loses its normal load-bearing architecture. Critically, true chronic tendinopathy often shows little to no active inflammation on biopsy. This distinction matters enormously for treatment selection.

Here is where many athletes get stuck: an acute tendinitis that is not properly addressed transitions over weeks or months into tendinopathy. The pain remains, but the underlying biology has shifted. Treatments designed to reduce inflammation — like NSAIDs or corticosteroids — may offer limited benefit at this stage because inflammation is no longer the primary driver of pain and dysfunction.

Common locations in active populations include the rotator cuff tendons in overhead athletes, the patellar tendon in runners and jumpers, and the Achilles tendon in endurance athletes and court sport players. Each of these sites is vulnerable to the acute-to-chronic transition when initial management is incomplete.

Cortisone Injections for Tendon Pain: What to Expect

Corticosteroids are potent anti-inflammatory agents. When injected near an affected tendon, they inhibit the inflammatory cascade — suppressing prostaglandins, cytokines, and immune cell activity that drive acute pain and swelling. The result is often rapid and meaningful pain relief, sometimes within 48 to 72 hours, with effects that can last several weeks to a few months.

For acute tendon pain treatment — where genuine inflammation is present and the condition is early — cortisone injections can be genuinely useful. They can break a pain cycle that is preventing participation in physical therapy, and they are relatively low-cost and widely covered by insurance.

However, the limitations are important and should not be minimized:

• Tendon weakening with repeated injections: Multiple corticosteroid injections into or immediately adjacent to a tendon have been associated with increased risk of tendon degeneration and, in some cases, rupture. Most guidelines recommend limiting injections to two or three at a given site, with careful spacing.
• Limited evidence for chronic tendinopathy: Several systematic reviews have found that while cortisone provides superior short-term pain relief compared to other treatments, outcomes at six to twelve months are often no better than — and sometimes worse than — physical therapy alone or placebo.
• Rebound pain: Some patients experience a return of symptoms, sometimes more intensely, after the corticosteroid effect wears off. This can be especially frustrating for athletes who returned to full activity during the pain-free window.

Cortisone is most appropriately considered during the acute inflammatory phase of tendon injury, when conservative care alone is insufficient to manage pain enough to allow rehabilitation, or when a short-term pain reduction is needed for a specific event or functional goal.

PRP Injections and Chronic Tendinitis: Current Research

Platelet-rich plasma is derived from the patient's own blood. A sample is drawn, then centrifuged to concentrate the platelets, which are rich in growth factors including PDGF, TGF-β, VEGF, and IGF-1. These growth factors are involved in tissue repair cascades, and the rationale behind PRP injections is that delivering a concentrated dose directly to degenerated tendon tissue may stimulate a healing response that chronic tendinopathy has failed to generate on its own.

The biological logic is sound. The clinical evidence is more nuanced.

Research on PRP for tendon disorders has grown substantially over the past decade. Some of the more consistent evidence supports PRP for chronic tendinitis conditions such as lateral epicondylitis (tennis elbow) and patellar tendinopathy, where multiple randomized controlled trials have demonstrated benefits in pain and function at three to twelve months compared to corticosteroid injection or placebo. Results for rotator cuff and Achilles tendinopathy are mixed and still evolving.

Key limitations to understand:

• PRP preparation variability: Not all PRP is the same. Platelet concentration, leukocyte content, and activation method differ across providers and systems, which complicates direct comparison between studies and between clinics.
• Longer timeline to effectiveness: Unlike cortisone, PRP does not provide rapid pain relief. Patients often experience temporary discomfort after the procedure and may not notice significant improvement for six to twelve weeks. This timeline requires patience that some athletes find difficult.
• Not yet standard of care universally: PRP is not FDA-approved as a treatment for specific tendon conditions, and insurance coverage is generally limited. It is an evidence-informed option for select conditions, not a guaranteed solution.

PRP is most appropriate to consider in cases of confirmed chronic tendinopathy that have not responded adequately to structured physical therapy and other conservative measures, and where the patient understands the realistic timeline and expectations.

Head-to-Head Comparison: PRP vs. Cortisone Injections

Neither treatment is universally superior. The appropriate choice depends on the chronicity of your condition, the tissue quality, your activity goals, and your timeline.

Beyond Injections: Conservative and Complementary Treatments

Injections — of any type — are not a standalone solution for persistent tendon pain. The most durable outcomes come from pairing injection therapy with a structured rehabilitation program.

Eccentric strengthening protocols have among the strongest evidence bases for chronic tendinopathy, particularly Achilles and patellar conditions. Eccentric exercises place load on the tendon during lengthening, which promotes collagen remodeling and fiber reorganization over time.

Physical therapy addresses not just the tendon itself but the biomechanical contributors — weakness, movement patterns, training errors — that created the problem in the first place. Without correcting these upstream factors, recurrence is likely regardless of injection choice.

Activity modification does not mean stopping entirely. It means restructuring training load so the tendon can adapt without being constantly re-aggravated. A sports medicine specialist can help design a modified program that maintains fitness while protecting healing tissue.

Sleep, nutrition (particularly adequate protein intake), and stress management all influence tissue healing and should be part of any comprehensive approach to tendon pain treatment.

Imaging — either musculoskeletal ultrasound or MRI — can confirm diagnosis and help identify whether the tendon has structural changes that inform treatment selection. Not all tendon pain needs an injection, and not all tendon conditions will respond to the same one.

Tendinitis Treatment Princeton NJ: Working with a Specialist

The most important step in managing persistent tendon pain is getting an accurate diagnosis before selecting a treatment. Self-diagnosis based on location of pain is unreliable, and selecting cortisone or PRP without confirming what stage and type of tendon pathology you have is a common source of treatment failure.

At NASPAC, Dr. Kodery works with athletes and active individuals to provide a thorough musculoskeletal evaluation that includes clinical assessment and, when indicated, diagnostic imaging to characterize tendon pathology accurately. The approach is individualized — considering the specific tendon involved, chronicity of injury, prior treatments, activity goals, and overall health — rather than defaulting to a single intervention.

Whether you are a competitive athlete trying to return to sport, a weekend warrior who simply wants to run again without pain, or a fitness professional whose livelihood depends on physical capacity, a personalized evaluation gives you a clear picture of what is happening and what your realistic options are. (Note: Confirm Dr. Kodery's current Princeton schedule and PRP availability when scheduling your appointment.)

What to Expect: Timeline and Recovery

Both injection procedures are performed in an office setting and take only a few minutes once preparation is complete. The significant difference is what happens afterward.

With cortisone, most patients experience rapid pain reduction and can return to light activity within 48 hours. The temptation here is to overdo it — pain relief is not the same as tissue healing, and returning to full training too soon can accelerate structural damage.

With PRP, expect a recovery arc measured in weeks, not days. Post-injection soreness is common in the first few days. A structured rehabilitation program typically begins within one to two weeks and progresses gradually. The reward for this slower timeline may be more durable improvement.

If your first treatment approach is not producing meaningful results by the agreed-upon checkpoint, that is valuable information — not a failure. It informs the next step in your care plan.

Conclusion: Making the Right Call for Your Tendon

Both cortisone and PRP injections have legitimate roles in managing tendon pain. Cortisone offers rapid, predictable short-term relief and is well-suited for acute inflammatory presentations. PRP represents a biologically driven option for chronic, degenerative tendinopathy where conventional approaches have fallen short — though it requires realistic expectations about timeline and is not universally effective.

The worst outcome is choosing based on convenience, cost alone, or someone else's experience without accounting for your specific diagnosis. The best outcome starts with a proper evaluation.

If persistent tendon pain is limiting your training, competition, or daily function, schedule a consultation with NASPAC today. Dr. Kodery and the team can evaluate your condition, confirm your diagnosis, and walk you through which treatment approach — or combination of approaches — is most appropriate for your goals. Don't let chronic tendinitis dictate your limits. Get the right information and get back to what you do best.

Contact NASPAC to schedule your evaluation and discuss your options for tendinitis treatment in Princeton, NJ.